Search
Now showing items 1-4 of 4
“INCORPORACIÓN DEL BIOMARCADOR ALFA-FETOPROTEÍNA COMO CRITERIO DE SELECCIÓN PARA TRASPLANTE HEPÁTICO POR HEPATOCARCINOMA”.
(2020)
El trasplante hepático es una de las terapéuticas curativas en pacientes con
hepatocarcinoma (HCC) o carcinoma hepatocelular. Sin embargo, la
recurrencia post trasplante hepático es un evento temible, con pobre sobrevida ...
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
(Elsevier, 2021-06)
Abstract
Background & aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated ...
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
(Springer, 2021-11)
Abstract
Introduction and objectives: Viral infections have been described to increase the risk of decompensation in patients with cirrhosis. We aimed to determine the effect of SARS-CoV-2 infection on outcome of hospitalized ...